2024 Clinical Practice Diabetes Provider 
GeriPal
JANUARY 23, 2025
In our third segment, we explore Amy Linskys study that examined the effect of patient-directed educational materials on clinician deprescribing of potentially low-benefit or high-risk medications, such as proton pump inhibitors, high-dose gabapentin, or risky diabetes medications. Ethical and practical. Connie 14:57 Yeah.
GeriPal
JUNE 20, 2024
Accreditation In support of improving patient care, UCSF Office of CME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ABIM
JUNE 4, 2025
Christine Twining, MD, Chair, ABIM Endocrinology, Diabetes and Metabolism Board The Endocrinology, Diabetes and Metabolism Board , which meets twice a year and is responsible for oversight of policy and assessment in the specialty, held its spring meeting on April 1, 2025. The following is a summary of the spring meeting.
GeriPal
JANUARY 18, 2024
It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. ABIM MOC credit will be offered to subscribers in November, 2024. Why would CBT work for neuropathic pain and diabetes differently than it would work for neuropathic pain and cancer?
GeriPal
JUNE 13, 2024
I feel like I recognize it when I see it, but I struggle to give a clear definition or provide effective ways to address it. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. It can be quite problematic in people with diabetes and so on.
Expert insights. Personalized for you.
119 
Let's personalize your content